Kymera Therapeutics (KYMR) EBITDA Margin Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Kymera Therapeutics |
8.84 Bn |
8.19 Bn |
- |
7,138.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
7,138.00 |
| Dec 31, 2025 |
-201,720.00 |
| Sep 30, 2025 |
-136,623.00 |
| Jun 30, 2025 |
-49,943.00 |
| Mar 31, 2025 |
19,364.00 |
| Dec 31, 2024 |
-97,704.00 |
| Sep 30, 2024 |
-46,950.00 |
| Jun 30, 2024 |
7,334.00 |
| Mar 31, 2024 |
-7,175.00 |
| Dec 31, 2023 |
18,401.00 |
| Sep 30, 2023 |
-62,266.00 |
| Jun 30, 2023 |
11,772.00 |
| Mar 31, 2023 |
-437.00 |
| Dec 31, 2022 |
1,524.00 |
| Sep 30, 2022 |
-32,918.00 |
| Jun 30, 2022 |
-22,321.00 |
| Mar 31, 2022 |
-33,852.00 |
| Dec 31, 2021 |
-12,636.00 |
| Sep 30, 2021 |
-8,497.00 |
| Jun 30, 2021 |
29,812.00 |
